abituzumab QVQLQQSGG-ELAKPGASVKVSCKASGYTF----SSFWMHWVRQAPGQGLEWIGYINPR--SGYTEYNEIFR-DKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGR-------------------GAMDYWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASQDI------SNYLAWYQQKPGKAPKLLIYYT-------SKIHSGVP-SRFSGSG--SGTDYTFTISSLQPEDIATYYCQQGNT----FPYTFGQGTKVEIK
abrilumab QVQLVQSGA-EVKKPGASVKVSCKVSGYTL----SDLSIHWVRQAPGKGLEWMGGFDPQ--DGETIYAQKFQ-GRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSS-------------------SWFDPWGQGTLVTVSSDIQMTQSPSSVSASVGDRVTITCRASQGI------SSWLAWYQQKPGKAPKLLIYGA-------SNLESGVP-SRFSGSG--SGTDFTLTISSLQPEDFANYYCQQANS----FPWTFGQGTKVEIK
adalimumab EVQLVESGG-GLVQPGRSLRLSCAASGFTF----DDYAMHWVRQAPGKGLEWVSAITWN--SGHIDYADSVE-GRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLS----------------TASSLDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQGI------RNYLAWYQQKPGKAPKLLIYAA-------STLQSGVP-SRFSGSG--SGTDFTLTISSLQPEDVATYYCQRYNR----APYTFGQGTKVEIK
alemtuzumab QVQLQESGP-GLVRPSQTLSLTCTVSGFTF----TDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVK-GRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHT------------------AAPFDYWGQGSLVTVSSDIQMTQSPSSLSASVGDRVTITCKASQNI------DKYLNWYQQKPGKAPKLLIYNT-------NNLQTGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYYCLQHIS----RPRTFGQGTKVEIK
alirocumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----NNYAMNWVRQAPGKGLDWVSTISGS--GGTTNYADSVK-GRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNW-------------------GNFDLWGRGTLVTVSSDIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWA-------STRESGVP-DRFSGSG--SGTDFTLTISSLQAEDVAVYYCQQYYT----TPYTFGQGTKLEIK
anifrolumab EVQLVQSGA-EVKKPGESLKISCKGSGYIF----TNYWIAWVRQMPGKGLESMGIIYPG--DSDIRYSPSFQ-GQVTISADKSITTAYLQWSSLKASDTAMYYCARHDI--------------------EGFDYWGRGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVS-----SSFFAWYQQKPGQAPRLLIYGA-------SSRATGIP-DRLSGSG--SGTDFTLTITRLEPEDFAVYYCQQYDS----SAITFGQGTRLEIK
atezolizumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----SDSWIHWVRQAPGKGLEWVAWISPY--GGSTYYADSVK-GRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWP-------------------GGFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQDV------STAVAWYQQKPGKAPKLLIYSA-------SFLYSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYLY----HPATFGQGTKVEIK
bapineuzumab EVQLLESGG-GLVQPGGSLRLSCAASGFTF----SNYGMSWVRQAPGKGLEWVASIRSG--GGRTYYSDNVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHY------------------SGSSDYWGQGTLVTVSSDVVMTQSPLSLPVTPGEPASISCKSSQSLLDS-DGKTYLNWLLQKPGQSPQRLIYLV-------SKLDSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCWQGTH----FPRTFGQGTKVEIK
basiliximab QVQLQQSGT-VLARPGASVKMSCKASGYSF----TRYWMHWIKQRPGQGLEWIGAIYPG--NSDTSYNQKFE-GKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYG--------------------YYFDFWGQGTTLTVSSQIVSTQSPAIMSASPGEKVTMTCSASSSR-------SYMQWYQQKPGTSPKRWIYDT-------SKLASGVP-ARFSGSG--SGTSYSLTISSMEAEDAATYYCHQRS------SYTFGGGTKLEIK
bavituximab EVQLQQSGP-ELEKPGASVKLSCKASGYSF----TGYNMNWVKQSHGKSLEWIGHIDPY--YGDTSYNQKFR-GKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYG-----------------HWYFDVWGAGTTVTVSSDIQMTQSPSSLSASLGERVSLTCRASQDI------GSSLNWLQQGPDGTIKRLIYAT-------SSLDSGVP-KRFSGSR--SGSDYSLTISSLESEDFVDYYCLQYVS----SPPTFGAGTKLELK
belimumab QVQLQQSGA-EVKKPGSSVRVSCKASGGTF----NNNAINWVRQAPGQGLEWMGGIIPM--FGTAKYSQNFQ-GRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLL--------------FPHHALSPWGRGTMVTVSSSSELTQDPA-VSVALGQTVRVTCQGDSLR------SYYASWYQQKPGQAPVLVIYGK-------NNRPSGIP-DRFSGSS--SGNTASLTITGAQAEDEADYYCSSRDSS--GNHWVFGGGTELTVL
benralizumab EVQLVQSGA-EVKKPGASVKVSCKASGYTF----TSYVIHWVRQRPGQGLAWMGYINPY--NDGTKYNERFK-GKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRY----------------YGLLGDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCGTSEDI------INYLNWYQQKPGKAPKLLIYHT-------SRLQSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQGYT----LPYTFGQGTKVEIK
bevacizumab EVQLVESGG-GLVQPGGSLRLSCAASGYTF----TNYGMNWVRQAPGKGLEWVGWINTY--TGEPTYAADFK-RRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYG--------------SSHWYFDVWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCSASQDI------SNYLNWYQQKPGKAPKVLIYFT-------SSLHSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYST----VPWTFGQGTKVEIK
bimagrumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TSSYINWVRQAPGQGLEWMGTINPV--SGSTSYAQKFQ-GRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGG----------------------WFDYWGQGTLVTVSSQSALTQPAS-VSGSPGQSITISCTGTSSDVG---SYNYVNWYQQHPGKAPKLMIYGV-------SKRPSGVS-NRFSGSK--SGNTASLTISGLQAEDEADYYCGTFAGG--SYYGVFGGGTKLTVL
blosozumab QVQLVQSGA-EVKKPGASVKVSCKVSGFPI----KDTFQHWVRQAPGKGLEWMGWSDPE--IGDTEYASKFQ-GRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTT-------------------YKFDFWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCKASQDV------HTAVAWYQQKPGKAPKLLIYWA-------STRWTGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYSD----YPWTFGGGTKVEIK
bococizumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TSYYMHWVRQAPGQGLEWMGEISPF--GGRTNYNEKFK-SRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPL-------------------YASDLWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASQGI------SSALAWYQQKPGKAPKLLIYSA-------SYRYTGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYYCQQRYS----LWRTFGQGTKLEIK
brentuximab QIQLQQSGP-EVVKPGASVKISCKASGYTF----TDYYITWVKQKPGQGLEWIGWIYPG--SGNTKYNEKFK-GKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGN--------------------YWFAYWGQGTQVTVSADIVLTQSPASLAVSLGQRATISCKASQSVDF--DGDSYMNWYQQKPGQPPKVLIYAA-------SNLESGIP-ARFSGSG--SGTDFTLNIHPVEEEDAATYYCQQSNE----DPWTFGGGTKLEIK
briakinumab QVQLVESGG-GVVQPGRSLRLSCAASGFTF----SSYGMHWVRQAPGKGLEWVAFIRYD--GSNKYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHG----------------------SHDNWGQGTMVTVSSQSVLTQPPS-VSGAPGQRVTISCSGSRSNI----GSNTVKWYQQLPGTAPKLLIYYN-------DQRPSGVP-DRFSGSK--SGTSASLAITGLQAEDEADYYCQSYDRY-THPALLFGTGTKVTVL
brodalumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TRYGISWVRQAPGQGLEWMGWISTY--SGNTNYAQKLQ-GRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQL---------------------YFDYWGQGTLVTVSSEIVMTQSPATLSVSPGERATLSCRASQSV------SSNLAWFQQKPGQAPRPLIYDA-------STRATGVP-ARFSGSG--SGTDFTLTISSLQSEDFAVYYCQQYDN----WPLTFGGGTKVEIK
canakinumab QVQLVESGG-GVVQPGRSLRLSCAASGFTF----SVYGMNWVRQAPGKGLEWVAIIWYD--GDNQYYADSVK-GRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRT-------------------GPFDYWGQGTLVTVSSEIVLTQSPDFQSVTPKEKVTITCRASQSI------GSSLHWYQQKPDQSPKLLIKYA-------SQSFSGVP-SRFSGSG--SGTDFTLTINSLEAEDAAAYYCHQSSS----LPFTFGPGTKVDIK
carlumab QVQLVQSGA-EVKKPGSSVKVSCKASGGTF----SSYGISWVRQAPGQGLEWMGGIIPI--FGTANYAQKFQ-GRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGI------------------YGELDFWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSVS-----DAYLAWYQQKPGQAPRLLIYDA-------SSRATGVP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCHQYIQ---LHSFTFGQGTKVEIK
certolizumab EVQLVESGG-GLVQPGGSLRLSCAASGYVF----TDYGMNWVRQAPGKGLEWMGWINTY--IGEPIYADSVK-GRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRS-------------------YAMDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASQNV------GTNVAWYQQKPGKAPKALIYSA-------SFLYSGVP-YRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYNI----YPLTFGQGTKVEIK
cetuximab QVQLKQSGP-GLVQPSQSLSITCTVSGFSL----TNYGVHWVRQSPGKGLEWLGVIWSG---GNTDYNTPFT-SRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYY-----------------DYEFAYWGQGTLVTVSADILLTQSPVILSVSPGERVSFSCRASQSI------GTNIHWYQQRTNGSPRLLIKYA-------SESISGIP-SRFSGSG--SGTDFTLSINSVESEDIADYYCQQNNN----WPTTFGAGTKLELK
cixutumumab EVQLVQSGA-EVKKPGSSVKVSCKASGGTF----SSYAISWVRQAPGQGLEWMGGIIPI--FGTANYAQKFQ-GRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWST-------QDHYYYYYMDVWGKGTTVTVSSSSELTQDPA-VSVALGQTVRITCQGDSLR------SYYATWYQQKPGQAPILVIYGE-------NKRPSGIP-DRFSGSS--SGNTASLTITGAQAEDEADYYCKSRDGS--GQHLVFGGGTKLTVL
clazakizumab EVQLVESGG-GLVQPGGSLRLSCAASGFSL----SNYYVTWVRQAPGKGLEWVGIIYGS---DETAYATSAI-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSD----------------WDAKFNLWGQGTLVTVSSAIQMTQSPSSLSASVGDRVTITCQASQSI------NNELSWYQQKPGKAPKLLIYRA-------STLASGVP-SRFSGSG--SGTDFTLTISSLQPDDFATYYCQQGYSL-RNIDNAFGGGTKVEIK
codrituzumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TDYEMHWVRQAPGQGLEWMGALDPK--TGDTAYSQKFK-GRVTLTADKSTSTAYMELSSLTSEDTAVYYCTRFY----------------------SYTYWGQGTLVTVSSDVVMTQSPLSLPVTPGEPASISCRSSQSLVHS-NRNTYLHWYLQKPGQSPQLLIYKV-------SNRFSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCSQNTH----VPPTFGQGTKLEIK
crenezumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----SSYGMSWVRQAPGKGLELVASINSN--GGSTYYPDSVK-GRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASG-------------------------DYWGQGTTVTVSSDIVMTQSPLSLPVTPGEPASISCRSSQSLVYS-NGDTYLHWYLQKPGQSPQLLIYKV-------SNRFSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCSQSTH----VPWTFGQGTKVEIK
dacetuzumab EVQLVESGG-GLVQPGGSLRLSCAASGYSF----TGYYIHWVRQAPGKGLEWVARVIPN--AGGTSYNQKFK-GRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREG-----------------------IYWWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRSSQSLVHS-NGNTFLHWYQQKPGKAPKLLIYTV-------SNRFSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYFCSQTTH----VPWTFGQGTKVEIK
daclizumab QVQLVQSGA-EVKKPGSSVKVSCKASGYTF----TSYRMHWVRQAPGQGLEWIGYINPS--TGYTEYNQKFK-DKATITADESTNTAYMELSSLRSEDTAVYYCARGGG---------------------VFDYWGQGTLVTVSSDIQMTQSPSTLSASVGDRVTITCSASSSI-------SYMHWYQQKPGKAPKLLIYTT-------SNLASGVP-ARFSGSG--SGTEFTLTISSLQPDDFATYYCHQRST----YPLTFGQGTKVEVK
dalotuzumab QVQLQESGP-GLVKPSETLSLTCTVSGYSIT---GGYLWNWIRQPPGKGLEWIGYISYD---GTNNYKPSLK-DRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGR--------------------VFFDYWGQGTLVTVSSDIVMTQSPLSLPVTPGEPASISCRSSQSIVHS-NGNTYLQWYLQKPGQSPQLLIYKV-------SNRLYGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCFQGSH----VPWTFGQGTKVEIK
daratumumab EVQLLESGG-GLVQPGGSLRLSCAVSGFTF----NSFAMSWVRQAPGKGLEWVSAISGS--GGGTYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWF---------------GEPVFDYWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSN----WPPTFGQGTKVEIK
denosumab EVQLLESGG-GLVQPGGSLRLSCAASGFTF----SSYAMSWVRQAPGKGLEWVSGITGS--GGSTYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTV---------------IMSWFDPWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVR-----GRYLAWYQQKPGQAPRLLIYGA-------SSRATGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVFYCQQYGS----SPRTFGQGTKVEIK
dinutuximab EVQLLQSGP-ELEKPGASVMISCKASGSSF----TGYNMNWVRQNIGKSLEWIGAIDPY--YGGTSYNQKFK-GRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSG------------------------MEYWGQGTSVTVSSEIVMTQSPATLSVSPGERATLSCRSSQSLVHR-NGNTYLHWYLQKPGQSPKLLIHKV-------SNRFSGVP-DRFSGSG--SGTDFTLKISRVEAEDLGVYFCSQSTH---VPPLTFGAGTKLELK
drozitumab EVQLVQSGG-GVERPGGSLRLSCAASGFTF----DDYAMSWVRQAPGKGLEWVSGINWQ--GGSTGYADSVK-GRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAG----------------RGWYFDYWGKGTTVTVSS-SELTQDPA-VSVALGQTVRITCSGDSLR------SYYASWYQQKPGQAPVLVIYGA-------NNRPSGIP-DRFSGSS--SGNTASLTITGAQAEDEADYYCNSADSS--GNHVVFGGGTKLTVL
duligotuzumab EVQLVESGG-GLVQPGGSLRLSCAASGFTL----SGDWIHWVRQAPGKGLEWVGEISAA--GGYTDYADSVK-GRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVS----------------FEAAMDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQNI------ATDVAWYQQKPGKAPKLLIYSA-------SFLYSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQSEP----EPYTFGQGTKVEIK
dupilumab EVQLVESGG-GLEQPGGSLRLSCAGSGFTF----RDYAMTWVRQAPGKGLEWVSSISGS--GGNTYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITI------------RPRYYGLDVWGQGTTVTVSSDIVMTQSPLSLPVTPGEPASISCRSSQSLLYS-IGYNYLDWYLQKSGQSPQLLIYLG-------SNRASGVP-DRFSGSG--SGTDFTLKISRVEAEDVGFYYCMQALQ----TPYTFGQGTKLEIK
eculizumab QVQLVQSGA-EVKKPGASVKVSCKASGYIF----SNYWIQWVRQAPGQGLEWMGEILPG--SGSTEYTENFK-DRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSS---------------PNWYFDVWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCGASENI------YGALNWYQQKPGKAPKLLIYGA-------TNLADGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQNVLN----TPLTFGQGTKVEIK
efalizumab EVQLVESGG-GLVQPGGSLRLSCAASGYSF----TGHWMNWVRQAPGKGLEWVGMIHPS--DSETRYNQKFK-DRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFY----------------GTTYFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASKTI------SKYLAWYQQKPGKAPKLLIYSG-------STLQSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQHNE----YPLTFGQGTKVEIK
eldelumab QMQLVESGG-GVVQPGRSLRLSCTASGFTF----SNNGMHWVRQAPGKGLEWVAVIWFD--GMNKFYVDSVK-GRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGI-------------YYYYGMDVWGQGTTVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVS-----SSYLAWYQQKPGQAPRLLIYGA-------SSRATGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQYGS---SPIFTFGPGTKVDIK
elotuzumab EVQLVESGG-GLVQPGGSLRLSCAASGFDF----SRYWMSWVRQAPGKGLEWIGEINPD--SSTINYAPSLK-DKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGN------------------YWYFDVWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASQDV------GIAVAWYQQKPGKVPKLLIYWA-------STRHTGVP-DRFSGSG--SGTDFTLTISSLQPEDVATYYCQQYSS----YPYTFGQGTKVEIK
emibetuzumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TDYYMHWVRQAPGQGLEWMGRVNPN--RRGTTYNQKFE-GRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARAN----------------------WLDYWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCSVSSSVS-----SIYLHWYQQKPGKAPKLLIYST-------SNLASGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQVYSG----YPLTFGGGTKVEIK
enokizumab QVQLVQSGA-EVKKPGSSVKVSCKASGGTF----SYYWIEWVRQAPGQGLEWMGEILPG--SGTTNPNEKFK-GRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGS---------------DYVKFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASQHV------ITHVTWYQQKPGKAPKLLIYGT-------SYSYSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQFYE----YPLTFGGGTKVEIK
epratuzumab QVQLVQSGA-EVKKPGSSVKVSCKASGYTF----TSYWLHWVRQAPGQGLEWIGYINPR--NDYTEYNQNFK-DKATITADESTNTAYMELSSLRSEDTAFYFCARRDI---------------------TTFYWGQGTTVTVSSDIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWA-------STRESGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYYCHQYL-----SSWTFGGGTKLEIK
etrolizumab EVQLVESGG-GLVQPGGSLRLSCAASGFFI----TNNYWGWVRQAPGKGLEWVGYISYS---GSTSYNPSLK-SRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSS-------------------GYFDFWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASESV------DDLLHWYQQKPGKAPKLLIKYA-------SQSISGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQGNS----LPNTFGQGTKVEIK
evolocumab EVQLVQSGA-EVKKPGASVKVSCKASGYTL----TSYGISWVRQAPGQGLEWMGWVSFY--NGNTNYAQKLQ-GRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGY----------------------GMDVWGQGTTVTVSSESALTQPAS-VSGSPGQSITISCTGTSSDVG---GYNSVSWYQQHPGKAPKLMIYEV-------SNRPSGVS-NRFSGSK--SGNTASLTISGLQAEDEADYYCNSYTS----TSMVFGGGTKLTVL
farletuzumab EVQLVESGG-GVVQPGRSLRLSCSASGFTF----SGYGLSWVRQAPGKGLEWVAMISSG--GSYTYYADSVK-GRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDD------------------PAWFAYWGQGTPVTVSSDIQLTQSPSSLSASVGDRVTITCSVSSSIS-----SNNLHWYQQKPGKAPKPWIYGT-------SNLASGVP-SRFSGSG--SGTDYTFTISSLQPEDIATYYCQQWSSY--PYMYTFGQGTKVEIK
fasinumab QVQLVQSGA-EVKKPGASVKVSCKVSGFTL----TELSIHWVRQAPGKGLEWMGGFDPE--DGETIYAQKFQ-GRVTMTEDTSTDTAYMELTSLRSEDTAVYYCSTIFGV------------------VTNFDNWGQGTLVTVSSDIQMTQSPSSLSASAGDRVTITCRASQAI------RNDLGWYQQKPGKAPKRLIYAA-------FNLQSGVP-SRFSGSG--SGTEFTLTISSLQPEDLASYYCQQYNR----YPWTFGQGTKVEIK
fezakinumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TNYYMHWVRQAPGQGLEWVGWINPY--TGSAFYAQKFR-GRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREPEKF----------------DSDDSDVWGRGTLVTVSSQAVLTQPPS-VSGAPGQRVTISCTGSSSNIG---AGYGVHWYQQLPGTAPKLLIYGD-------SNRPSGVP-DRFSGSK--SGTSASLAITGLQAEDEADYYCQSYDNS--LSGYVFGGGTQLTVL
ficlatuzumab QVQLVQPGA-EVKKPGTSVKLSCKASGYTF----TTYWMHWVRQAPGQGLEWIGEINPT--NGHTNYNQKFQ-GRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVG-------------------SIFDYWGQGTLLTVSSDIVMTQSPDSLAMSLGERVTLNCKASENV------VSYVSWYQQKPGQSPKLLIYGA-------SNRESGVP-DRFSGSG--SATDFTLTISSVQAEDVADYHCGQSYN----YPYTFGQGTKLEIK
figitumumab EVQLLESGG-GLVQPGGSLRLSCTASGFTF----SSYAMNWVRQAPGKGLEWVSAISGS--GGTTFYADSVK-GRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDS------------YYYYYGMDVWGQGTTVTVSSDIQMTQFPSSLSASVGDRVTITCRASQGI------RNDLGWYQQKPGKAPKRLIYAA-------SRLHRGVP-SRFSGSG--SGTEFTLTISSLQPEDFATYYCLQHNS----YPCSFGQGTKLEIK
fletikumab QVQLVQSGA-EVKRPGASVKVSCKASGYTF----TNDIIHWVRQAPGQRLEWMGWINAG--YGNTQYSQNFQ-DRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGES----------SPHDYYGMDVWGQGTTVTVSSAIQLTQSPSSLSASVGDRVTITCRASQGI------SSALAWYQQKPGKAPKLLIYDA-------SSLESGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQFNS----YPLTFGGGTKVEIK
foralumab QVQLVESGG-GVVQPGRSLRLSCAASGFKF----SGYGMHWVRQAPGKGLEWVAVIWYD--GSKKYYVDSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGY-------------------WHFDLWGRGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSN---WPPLTFGGGTKVEIK
fresolimumab QVQLVQSGA-EVKKPGSSVKVSCKASGYTF----SSNVISWVRQAPGQGLEWMGGVIPI--VDIANYAQRFK-GRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLV-----------------LDAMDYWGQGTLVTVSSETVLTQSPGTLSLSPGERATLSCRASQSLG-----SSYLAWYQQKPGQAPRLLIYGA-------SSRAPGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQYAD----SPITFGQGTRLEIK
fulranumab EVQLVESGG-GLVQPGGSLRLSCAASGFTL----RSYSMNWVRQAPGKGLEWVSYISRS--SHTIFYADSVK-GRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGW--------------HVSDYFDYWGQGILVTVSSAIQLTQSPSSLSASVGDRVTITCRASQGI------SSALAWYQQKPGKAPKLLIYDA-------SSLESGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQFNS----YPLTFGGGTKVEIK
galiximab QVQLQESGP-GLVKPSETLSLTCAVSGGSIS---GGYGWGWIRQPPGKGLEWIGSFYSS--SGNTYYNPSLK-SQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVG-----------MVYNNWFDVWGPGVLVTVSSESALTQPPS-VSGAPGQKVTISCTGSTSNI----GGYDLHWYQQLPGTAPKLLIYDI-------NKRPSGIS-DRFSGSK--SGTAASLAITGLQTEDEADYYCQSYDSS--LNAQVFGGGTRLTVL
ganitumab QVQLQESGP-GLVKPSGTLSLTCAVSGGSIS---SSNWWSWVRQPPGKGLEWIGEIYHS---GSTNYNPSLK-SRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGR------------------TDAFDIWGQGTMVTVSSDVVMTQSPLSLPVTPGEPASISCRSSQSLLHS-NGYNYLDWYLQKPGQSPQLLIYLG-------SNRASGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCMQGTH----WPLTFGQGTKVEIK
gantenerumab QVELVESGG-GLVQPGGSLRLSCAASGFTF----SSYAMSWVRQAPGKGLEWVSAINAS--GTRTYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKP-----------YGYVRYFDVWGQGTLVTVSSDIVLTQSPATLSLSPGERATLSCRASQSVS-----SSYLAWYQQKPGQAPRLLIYGA-------SSRATGVP-ARFSGSG--SGTDFTLTISSLEPEDFATYYCLQIYN----MPITFGQGTKVEIK
gemtuzumab EVQLVQSGA-EVKKPGSSVKVSCKASGYTI----TDSNIHWVRQAPGQSLEWIGYIYPY--NGGTDYNQKFK-NRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNP---------------------WLAYWGQGTLVTVSSDIQLTQSPSTLSASVGDRVTITCRASESLDN--YGIRFLTWFQQKPGKAPKLLMYAA-------SNQGSGVP-SRFSGSG--SGTEFTLTISSLQPDDFATYYCQQTKE----VPWSFGQGTKVEVK
gevokizumab QVQLQESGP-GLVKPSQTLSLTCSFSGFSLS--TSGMGVGWIRQPSGKGLEWLAHIWWD---GDESYNPSLK-SRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYD------------------PPWFVDWGQGTLVTVSSDIQMTQSTSSLSASVGDRVTITCRASQDI------SNYLSWYQQKPGKAVKLLIYYT-------SKLHSGVP-SRFSGSG--SGTDYTLTISSLQQEDFATYFCLQGKM----LPWTFGQGTKLEIK
girentuximab DVKLVESGG-GLVKLGGSLKLSCAASGFTF----SNYYMSWVRQTPEKRLELVAAINSD--GGITYYLDTVK-GRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSG------------------YFSMDYWGQGTSVTVSSDIVMTQSQRFMSTTVGDRVSITCKASQNV------VSAVAWYQQKPGQSPKLLIYSA-------SNRYTGVP-DRFTGSG--SGTDFTLTISNMQSEDLADFFCQQYSN----YPWTFGGGTKLEIK
glembatumumab QVQLQESGP-GLVKPSQTLSLTCTVSGGSIS--SFNYYWSWIRHHPGKGLEWIGYIYYS---GSTYSNPSLK-SRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNW-------------------NYFDYWGQGTLVTVSSEIVMTQSPATLSVSPGERATLSCRASQSV------DNNLVWYQQKPGQAPRLLIYGA-------STRATGIP-ARFSGSG--SGTEFTLTISSLQSEDFAVYYCQQYNN---WPPWTFGQGTKVEIK
golimumab QVQLVESGG-GVVQPGRSLRLSCAASGFIF----SSYAMHWVRQAPGNGLEWVAFMSYD--GSNKKYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGG-----------NYYYYGMDVWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------YSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSN---WPPFTFGPGTKVDIK
guselkumab EVQLVQSGA-EVKKPGESLKISCKGSGYSF----SNYWIGWVRQMPGKGLEWMGIIDPS--NSYTRYSPSFQ-GQVTISADKSISTAYLQWSSLKASDTAMYYCARWYY--------------------KPFDVWGQGTLVTVSSQSVLTQPPS-VSGAPGQRVTISCTGSSSNIG---SGYDVHWYQQLPGTAPKLLIYGN-------SKRPSGVP-DRFSGSK--SGTSASLAITGLQSEDEADYYCASWTDG--LSLVVFGGGTKLTVL
ibalizumab QVQLQQSGP-EVVKPGASVKMSCKASGYTF----TSYVIHWVRQKPGQGLDWIGYINPY--NDGTDYDEKFK-GKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYA---------------TGAWFAYWGQGTLVTVSSDIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWA-------STRESGVP-DRFSGSG--SGTDFTLTISSVQAEDVAVYYCQQYY-----SYRTFGGGTKLEIK
imgatuzumab QVQLVQSGA-EVKKPGSSVKVSCKASGFTF----TDYKIHWVRQAPGQGLEWMGYFNPN--SGYSTYAQKFQ-GRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGG-----------------YYVMDAWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASQGI------NNYLNWYQQKPGKAPKRLIYNT-------NNLQTGVP-SRFSGSG--SGTEFTLTISSLQPEDFATYYCLQHN-----SFPTFGQGTKLEIK
infliximab EVKLEESGG-GLVQPGGSMKLSCVASGFIF----SNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVK-GRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYG-------------------STYDYWGQGTTLTVSSDILLTQSPAILSVSPGERVSFSCRASQFV------GSSIHWYQQRTNGSPRLLIKYA-------SESMSGIP-SRFSGSG--SGTDFTLSINTVESEDIADYYCQQSHS----WPFTFGSGTNLEVK
inotuzumab EVQLVQSGA-EVKKPGASVKVSCKASGYRF----TNYWIHWVRQAPGQGLEWIGGINPG--NNYATYRRKFQ-GRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGN----------------YGAWFAYWGQGTLVTVSSDVQVTQSPSSLSASVGDRVTITCRSSQSLANS-YGNTFLSWYLHKPGKAPQLLIYGI-------SNRFSGVP-DRFSGSG--SGTDFTLTISSLQPEDFATYYCLQGTH----QPYTFGQGTKVEIK
ipilimumab QVQLVESGG-GVVQPGRSLRLSCAASGFTF----SSYTMHWVRQAPGKGLEWVTFISYD--GNNKYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWL-------------------GPFDYWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVG-----SSYLAWYQQKPGQAPRLLIYGA-------FSRATGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQYGS----SPWTFGQGTKVEIK
ixekizumab QVQLVQSGA-EVKKPGSSVKVSCKASGYSF----TDYHIHWVRQAPGQGLEWMGVINPM--YGTTDYNQRFK-GRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYF------------------TGTGVYWGQGTLVTVSSDIVMTQTPLSLSVTPGQPASISCRSSRSLVHS-RGNTYLHWYLQKPGQSPQLLIYKV-------SNRFIGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCSQSTH----LPFTFGQGTKLEIK
lampalizumab EVQLVQSGP-ELKKPGASVKVSCKASGYTF----TNYGMNWVRQAPGQGLEWMGWINTY--TGETTYADDFK-GRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREG----------------------GVNNWGQGTLVTVSSDIQVTQSPSSLSASVGDRVTITCITSTDI------DDDMNWYQQKPGKVPKLLISGG-------NTLRPGVP-SRFSGSG--SGTDFTLTISSLQPEDVATYYCLQSDS----LPYTFGQGTKVEIK
lebrikizumab QVTLRESGP-ALVKPTQTLTLTCTVSGFSL----SAYSVNWIRQPPGKALEWLAMIWGD---GKIVYNSALK-SRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYY------------------PYAMDNWGQGSLVTVSSDIVMTQSPDSLSVSLGERATINCRASKSVDS--YGNSFMHWYQQKPGQPPKLLIYLA-------SNLESGVP-DRFSGSG--SGTDFTLTISSLQAEDVAVYYCQQNNE----DPRTFGGGTKVEIK
lenzilumab QVQLVQSGA-EVKKPGASVKVSCKASGYSF----TNYYIHWVRQAPGQRLEWMGWINAG--NGNTKYSQKFQ-GRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRF------------------PYYFDYWGQGTLVTVSSEIVLTQSPATLSVSPGERATLSCRASQSV------GTNVAWYQQKPGQAPRVLIYST-------SSRATGIT-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQFNK----SPLTFGGGTKVEIK
lintuzumab QVQLVQSGA-EVKKPGSSVKVSCKASGYTF----TDYNMHWVRQAPGQGLEWIGYIYPY--NGGTGYNQKFK-SKATITADESTNTAYMELSSLRSEDTAVYYCARGRP---------------------AMDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASESVDN--YGISFMNWFQQKPGKAPKLLIYAA-------SNQGSGVP-SRFSGSG--SGTDFTLTISSLQPDDFATYYCQQSKE----VPWTFGQGTKVEIK
lirilumab QVQLVQSGA-EVKKPGSSVKVSCKASGGTF----SFYAISWVRQAPGQGLEWMGGFIPI--FGAANYAQKFQ-GRVTITADESTSTAYMELSSLRSDDTAVYYCARIPSGSY--------------YYDYDMDVWGQGTTVTVSSEIVLTQSPVTLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSN----WMYTFGQGTKLEIK
lumiliximab EVQLVESGG-GLAKPGGSLRLSCAASGFRFT--FNNYYMDWVRQAPGQGLEWVSRISSS--GDPTWYADSVK-GRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTT---------------------GSDSWGQGVLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQDI------RYYLNWYQQKPGKAPKLLIYVA-------SSLQSGVP-SRFSGSG--SGTEFTLTVSSLQPEDFATYYCLQVYS----TPRTFGQGTKVEIK
matuzumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TSHWMHWVRQAPGQGLEWIGEFNPS--NGRTNYNEKFK-SKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDY----------------DGRYFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCSASSSV-------TYMYWYQQKPGKAPKLLIYDT-------SNLASGVP-SRFSGSG--SGTDYTFTISSLQPEDIATYYCQQWSS----HIFTFGQGTKVEIK
mavrilimumab QVQLVQSGA-EVKKPGASVKVSCKVSGYTL----TELSIHWVRQAPGKGLEWMGGFDPE--ENEIVYAQRFQ-GRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFS-----------------PLTLGLWGQGTMVTVSSQSVLTQPPS-VSGAPGQRVTISCTGSGSNIG---APYDVSWYQQLPGTAPKLLIYHN-------NKRPSGVP-DRFSGSK--SGTSASLAITGLQAEDEADYYCATVEAG--LSGSVFGGGTKLTVL
mepolizumab QVTLRESGP-ALVKPTQTLTLTCTVSGFSL----TSYSVHWVRQPPGKGLEWLGVIWAS---GGTDYNSALM-SRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSS-----------------LLRLDYWGRGTPVTVSSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGA-------STRESGVP-DRFSGSG--SGTDFTLTISSLQAEDVAVYYCQNVHS----FPFTFGGGTKLEIK
mogamulizumab EVQLVESGG-DLVQPGRSLRLSCAASGFIF----SNYGMSWVRQAPGKGLEWVATISSA--STYSYYPDSVK-GRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDG------------------NFAFGYWGQGTLVTVSSDVLMTQSPLSLPVTPGEPASISCRSSRNIVHI-NGDTYLEWYLQKPGQSPQLLIYKV-------SNRFSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCFQGSL----LPWTFGQGTKVEIK
motavizumab QVTLRESGP-ALVKPTQTLTLTCTFSGFSLS--TAGMSVGWIRQPPGKALEWLADIWWD---DKKHYNPSLK-DRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIF------------------NFYFDVWGQGTTVTVSSDIQMTQSPSTLSASVGDRVTITCSASSRV-------GYMHWYQQKPGKAPKLLIYDT-------SKLASGVP-SRFSGSG--SGTEFTLTISSLQPDDFATYYCFQGSG----YPFTFGGGTKVEIK
muromonab QVQLQQSGA-ELARPGASVKMSCKASGYTF----TRYTMHWVKQRPGQGLEWIGYINPS--RGYTNYNQKFK-DKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDD------------------HYCLDYWGQGTTLTVSSQIVLTQSPAIMSASPGEKVTMTCSASSSV-------SYMNWYQQKSGTSPKRWIYDT-------SKLASGVP-AHFRGSG--SGTSYSLTISGMEAEDAATYYCQQWSS----NPFTFGSGTKLEIK
natalizumab QVQLVQSGA-EVKKPGASVKVSCKASGFNI----KDTYIHWVRQAPGQRLEWMGRIDPA--NGYTKYDPKFQ-GRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGN--------------YGVYAMDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKTSQDI------NKYMAWYQQTPGKAPRLLIHYT-------SALQPGIP-SRFSGSG--SGRDYTFTISSLQPEDIATYYCLQYD-----NLWTFGQGTKVEIK
necitumumab QVQLQESGP-GLVKPSQTLSLTCTVSGGSIS--SGDYYWSWIRQPPGKGLEWIGYIYYS---GSTDYNPSLK-SRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFG-----------------VGTFDYWGQGTLVTVSSEIVMTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCHQYGS----TPLTFGGGTKAEIK
nimotuzumab QVQLQQSGA-EVKKPGSSVKVSCKASGYTF----TNYYIYWVRQAPGQGLEWIGGINPT--SGGSNFNEKFK-TRVTITADESSTTAYMELSSLRSEDTAFYFCTRQGLWFD--------------SDGRGFDFWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRSSQNIVHS-NGNTYLDWYQQTPGKAPKLLIYKV-------SNRFSGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYYCFQYSH----VPWTFGQGTKLQIT
nivolumab QVQLVESGG-GVVQPGRSLRLDCKASGITF----SNSGMHWVRQAPGKGLEWVAVIWYD--GSKRYYADSVK-GRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATN------------------------DDYWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQSSN----WPRTFGQGTKVEIK
obinutuzumab QVQLVQSGA-EVKKPGSSVKVSCKASGYAF----SYSWINWVRQAPGQGLEWMGRIFPG--DGDTDYNGKFK-GRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFD------------------GYWLVYWGQGTLVTVSSDIVMTQTPLSLPVTPGEPASISCRSSKSLLHS-NGITYLYWYLQKPGQSPQLLIYQM-------SNLVSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCAQNLE----LPYTFGGGTKVEIK
ocrelizumab EVQLVESGG-GLVQPGGSLRLSCAASGYTF----TSYNMHWVRQAPGKGLEWVGAIYPG--NGDTSYNQKFK-GRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSN---------------SYWYFDVWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASSSV-------SYMHWYQQKPGKAPKPLIYAP-------SNLASGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQWSF----NPPTFGQGTKVEIK
ofatumumab EVQLVESGG-GLVQPGRSLRLSCAASGFTF----NDYAMHWVRQAPGKGLEWVSTISWN--SGSIGYADSVK-GRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGN---------------YYYGMDVWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSN----WPITFGQGTRLEIK
olaratumab QLQLQESGP-GLVKPSETLSLTCTVSGGSIN--SSSYYWGWLRQSPGKGLEWIGSFFYT---GSTYYNPSLR-SRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGS-----------GNYYGWFDRWDQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSN----WPPAFGQGTKVEIK
olokizumab EVQLVESGG-GLVQPGGSLRLSCAASGFNF----NDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLE-GRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYY-------------------GFTSYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCQASQDI------GISLSWYQQKPGKAPKLLIYNA-------NNLADGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCLQHNS----APYTFGQGTKLEIK
omalizumab EVQLVESGG-GLVQPGGSLRLSCAVSGYSIT---SGYSWNWIRQAPGKGLEWVASITYD---GSTNYNPSLK-GRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYF----------------GHWHFAVWGQGTLVTVSSDIQLTQSPSSLSASVGDRVTITCRASQSVDY--DGDSYMNWYQQKPGKAPKLLIYAA-------SYLESGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQSHE----DPYTFGQGTKVEIK
onartuzumab EVQLVESGG-GLVQPGGSLRLSCAASGYTF----TSYWLHWVRQAPGKGLEWVGMIDPS--NSDTRFNPNFK-DRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSY------------------VTPLDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWA-------STRESGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYYA----YPWTFGQGTKVEIK
otelixizumab EVQLLESGG-GLVQPGGSLRLSCAASGFTF----SSFPMAWVRQAPGKGLEWVSTISTS--GGRTYYRDSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKFRQY------------------SGGFDYWGQGTLVTVSSDIQLTQPNS-VSTSLGSTVKLSCTLSSGNI----ENNYVHWYQLYEGRSPTTMIYDD-------DKRPDGVP-DRFSGSIDRSSNSAFLTIHNVAIEDEAIYFCHSYVS----SFNVFGGGTKLTVL
otlertuzumab EVQLVQSGA-EVKKPGESLKISCKGSGYSF----TGYNMNWVRQMPGKGLEWMGNIDPY--YGGTTYNRKFK-GQVTISADKSISTAYLQWSSLKASDTAMYYCARSVG---------------------PFDSWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASENV------YSYLAWYQQKPGQAPRLLIYFA-------KTLAEGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQHHSD----NPWTFGQGTKVEIK
ozanezumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TSYWMHWVRQAPGQGLEWIGNINPS--NGGTNYNEKFK-SKATMTRDTSTSTAYMELSSLRSEDTAVYYCELM------------------------QGYWGQGTLVTVSSDIVMTQSPLSNPVTLGQPVSISCRSSKSLLYK-DGKTYLNWFLQRPGQSPQLLIYLM-------STRASGVP-DRFSGGG--SGTDFTLKISRVEAEDVGVYYCQQLVE----YPLTFGQGTKLEIK
palivizumab QVTLRESGP-ALVKPTQTLTLTCTFSGFSLS--TSGMSVGWIRQPPGKALEWLADIWWD---DKKDYNPSLK-SRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMIT------------------NWYFDVWGAGTTVTVSSDIQMTQSPSTLSASVGDRVTITCKCQLSV-------GYMHWYQQKPGKAPKLLIYDT-------SKLASGVP-SRFSGSG--SGTEFTLTISSLQPDDFATYYCFQGSG----YPFTFGGGTKLEIK
panitumumab QVQLQESGP-GLVKPSETLSLTCTVSGGSVS--SGDYYWTWIRQSPGKGLEWIGHIYYS---GNTNYNPSLK-SRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVT-------------------GAFDIWGQGTMVTVSSDIQMTQSPSSLSASVGDRVTITCQASQDI------SNYLNWYQQKPGKAPKLLIYDA-------SNLETGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYFCQHFDH----LPLAFGGGTKVEIK
panobacumab EEQVVESGG-GFVQPGGSLRLSCAASGFTF----SPYWMHWVRQAPGKGLVWVSRINSD---GSTYYADSVK-GRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRY--------------------YGPEMWGQGTMVTVSSDVVMTQSPLSLPVTLGQPASISCRSSQSLVYS-DGNTYLNWFQQRPGQSPRRLIYKV-------SNRDSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCMQGTH----WPLTFGGGTKVEIK
parsatuzumab EVQLVESGG-GLVQPGGSLRLSCAASGYTF----IDYYMNWVRQAPGKGLEWVGDINLD--NSGTHYNQKFK-GRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHD--------------YDDYAMDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRTSQSLVHI-NAITYLHWYQQKPGKAPKLLIYRV-------SNRFSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCGQSTH----VPLTFGQGTKVEIK
patritumab QVQLQQWGA-GLLKPSETLSLTCAVYGGSF----SGYYWSWIRQPPGKGLEWIGEINHS---GSTNYNPSLK-SRVTISVETSKNQFSLKLSSVTAADTAVYYCARDKWT-------------------WYFDLWGRGTLVTVSSDIEMTQSPDSLAVSLGERATINCRSSQSVLYSSSNRNYLAWYQQNPGQPPKLLIYWA-------STRESGVP-DRFSGSG--SGTDFTLTISSLQAEDVAVYYCQQYYS----TPRTFGQGTKVEIK
pembrolizumab QVQLVQSGV-EVKKPGASVKVSCKASGYTF----TNYYMYWVRQAPGQGLEWMGGINPS--NGGTNFNEKFK-NRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRF-----------------DMGFDYWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCRASKGVST--SGYSYLHWYQQKPGQAPRLLIYLA-------SYLESGVP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQHSRD----LPLTFGGGTKVEIK
pertuzumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----TDYTMDWVRQAPGKGLEWVADVNPN--SGGSIYNQRFK-GRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGP------------------SFYFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASQDV------SIGVAWYQQKPGKAPKLLIYSA-------SYRYTGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYYI----YPYTFGQGTKVEIK
pinatuzumab EVQLVESGG-GLVQPGGSLRLSCAASGYEF----SRSWMNWVRQAPGKGLEWVGRIYPG--DGDTNYSGKFK-GRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSW-----------------DWYFDVWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRSSQSIVHS-VGNTFLEWYQQKPGKAPKLLIYKV-------SNRFSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCFQGSQ----FPYTFGQGTKVEIK
polatuzumab EVQLVESGG-GLVQPGGSLRLSCAASGYTF----SSYWIEWVRQAPGKGLEWIGEILPG--GGDTNYNEIFK-GRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVP--------------------IRLDYWGQGTLVTVSSDIQLTQSPSSLSASVGDRVTITCKASQSVDY--EGDSFLNWYQQKPGKAPKLLIYAA-------SNLESGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQSNE----DPLTFGQGTKVEIK
ponezumab QVQLVQSGA-EVKKPGASVKVSCKASGYYT----EAYYIHWVRQAPGQGLEWMGRIDPA--TGNTKYAPRLQ-DRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYS---------------------LPVYWGQGTTVTVSSDVVMTQSPLSLPVTLGQPASISCKSSQSLLYS-DAKTYLNWFQQRPGQSPRRLIYQI-------SRLDPGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCLQGTH----YPVLFGQGTRLEIK
radretumab EVQLLESGG-GLVQPGGSLRLSCAASGFTF----SSFSMSWVRQAPGKGLEWVSSISGS--SGTTYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFP---------------------YFDYWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVS-----SSFLAWYQQKPGQAPRLLIYYA-------SSRATGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQTGR----IPPTFGQGTKVEIK
ramucirumab EVQLVQSGG-GLVKPGGSLRLSCAASGFTF----SSYSMNWVRQAPGKGLEWVSSISSS--SSYIYYADSVK-GRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTD---------------------AFDIWGQGTMVTVSSDIQMTQSPSSVSASIGDRVTITCRASQGI------DNWLGWYQQKPGKAPKLLIYDA-------SNLDTGVP-SRFSGSG--SGTYFTLTISSLQAEDFAVYFCQQAKA----FPPTFGGGTKVDIK
ranibizumab EVQLVESGG-GLVQPGGSLRLSCAASGYDF----THYGMNWVRQAPGKGLEWVGWINTY--TGEPTYAADFK-RRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYG--------------TSHWYFDVWGQGTLVTVSSDIQLTQSPSSLSASVGDRVTITCSASQDI------SNYLNWYQQKPGKAPKVLIYFT-------SSLHSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYST----VPWTFGQGTKVEIK
reslizumab EVQLVESGG-GLVQPGGSLRLSCAVSGLSL----TSNSVNWIRQAPGKGLEWVGLIWSN---GDTDYNSAIK-SRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYY--------------------GYFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCLASEGI------SSYLAWYQQKPGKAPKLLIYGA-------NSLQTGVP-SRFSGSG--SATDYTLTISSLQPEDFATYYCQQSYK----FPNTFGQGTKVEVK
rilotumumab QVQLQESGP-GLVKPSETLSLTCTVSGGSI----SIYYWSWIRQPPGKGLEWIGYVYYS---GSTNYNPSLK-SRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDF----------------WSGYFDYWGQGTLVTVSSEIVMTQSPATLSVSPGERATLSCRASQSV------DSNLAWYRQKPGQAPRLLIYGA-------STRATGIP-ARFSGSG--SGTEFTLTISSLQSEDFAVYYCQQYIN---WPPITFGQGTRLEIK
rituximab QVQLQQPGA-ELVKPGASVKMSCKASGYTF----TSYNMHWVKQTPGRGLEWIGAIYPG--NGDTSYNQKFK-GKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYG----------------GDWYFNVWGAGTTVTVSAQIVLSQSPAILSASPGEKVTMTCRASSSV-------SYIHWFQQKPGSSPKPWIYAT-------SNLASGVP-VRFSGSG--SGTSYSLTISRVEAEDAATYYCQQWTS----NPPTFGGGTKLEIK
robatumumab EVQLVQSGG-GLVKPGGSLRLSCAASGFTF----SSFAMHWVRQAPGKGLEWISVIDTR---GATYYADSVK-GRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNF------------------YYGMDVWGQGTTVTVSSEIVLTQSPGTLSVSPGERATLSCRASQSI------GSSLHWYQQKPGQAPRLLIKYA-------SQSLSGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCHQSSR----LPHTFGQGTKVEIK
romosozumab EVQLVQSGA-EVKKPGASVKVSCKASGYTF----TDYNMHWVRQAPGQGLEWMGEINPN--SGGAGYNQKFK-GRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDI--------------YDDWYFDVWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASQDI------SNYLNWYQQKPGKAPKLLIYYT-------SRLLSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQGDT----LPYTFGGGTKVEIK
sarilumab EVQLVESGG-GLVQPGRSLRLSCAASRFTF----DDYAMHWVRQAPGKGLEWVSGISWN--SGRIGYADSVK-GRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRD---------------------SFDIWGQGTMVTVSSDIQMTQSPSSVSASVGDRVTITCRASQGI------SSWLAWYQQKPGKAPKLLIYGA-------SSLESGVP-SRFSGSG--SGTDFTLTISSLQPEDFASYYCQQANS----FPYTFGQGTKLEIK
secukinumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----SNYWMNWVRQAPGKGLEWVAAINQD--GSEKYYVGSVK-GRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTD----------YYIHYWYFDLWGRGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVS-----SSYLAWYQQKPGQAPRLLIYGA-------SSRATGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQYGS----SPCTFGQGTRLEIK
seribantumab EVQLLESGG-GLVQPGGSLRLSCAASGFTF----SHYVMAWVRQAPGKGLEWVSSISSS--GGWTLYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKM------------------ATIFDYWGQGTLVTVSSQSALTQPAS-VSGSPGQSITISCTGTSSDVG---SYNVVSWYQQHPGKAPKLIIYEV-------SQRPSGVS-NRFSGSK--SGNTASLTISGLQTEDEADYYCCSYAGS--SIFVIFGGGTKVTVL
sifalimumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TSYSISWVRQAPGQGLEWMGWISVY--NGNTNYAQKFQ-GRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPI---------------------AAGYWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASQSVS-----STYLAWYQQKPGQAPRLLIYGA-------SSRATGIP-DRFSGSG--SGTDFTLTISRLEPEDFAVYYCQQYGS----SPRTFGQGTKVEIK
siltuximab EVQLVESGG-KLLKPGGSLKLSCAASGFTF----SSFAMSWFRQSPEKRLEWVAEISSG--GSYTYYPDTVT-GRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWG------------------YYALDYWGQGTSVTVSSQIVLIQSPAIMSASPGEKVTMTCSASSSV-------SYMYWYQQKPGSSPRLLIYDT-------SNLASGVP-VRFSGSG--SGTSYSLTISRMEAEDAATYYCQQWSG----YPYTFGGGTKLEIK
simtuzumab QVQLVQSGA-EVKKPGASVKVSCKASGYAF----TYYLIEWVRQAPGQGLEWIGVINPG--SGGTNYNEKFK-GRATITADKSTSTAYMELSSLRSEDTAVYFCARNWM---------------------NFDYWGQGTTVTVSSDIVMTQTPLSLSVTPGQPASISCRSSKSLLHS-NGNTYLYWFLQKPGQSPQFLIYRM-------SNLASGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCMQHLE----YPYTFGGGTKVEIK
sirukumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----SPFAMSWVRQAPGKGLEWVAKISPG--GSWTYYSDTVT-GRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWG------------------YYALDIWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCSASISV-------SYMYWYQQKPGQAPRLLIYDM-------SNLASGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCMQWSG----YPYTFGGGTKVEIK
tabalumab QVQLQQWGA-GLLKPSETLSLTCAVYGGSF----SGYYWSWIRQPPGKGLEWIGEINHS---GSTNYNPSLK-SRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILT-------------GYYYYFDYWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SRYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDSTLTISSLEPEDFAVYYCQQRSN----WPRTFGQGTKVEIK
tanezumab QVQLQESGP-GLVKPSETLSLTCTVSGFSL----IGYDLNWIRQPPGKGLEWIGIIWGD---GTTDYNSAVK-SRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYA---------------TSYYFDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQSI------SNNLNWYQQKPGKAPKLLIYYT-------SRFHSGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYYCQQEHT----LPYTFGQGTKLEIK
teplizumab QVQLVQSGG-GVVQPGRSLRLSCKASGYTF----TRYTMHWVRQAPGKGLEWIGYINPS--RGYTNYNQKVK-DRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDD------------------HYCLDYWGQGTPVTVSSDIQMTQSPSSLSASVGDRVTITCSASSSV-------SYMNWYQQTPGKAPKRWIYDT-------SKLASGVP-SRFSGSG--SGTDYTFTISSLQPEDIATYYCQQWSS----NPFTFGQGTKLQIT
tigatuzumab EVQLVESGG-GLVQPGGSLRLSCAASGFTF----SSYVMSWVRQAPGKGLEWVATISSG--GSYTYYPDSVK-GRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDS------------------MITTDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASQDV------GTAVAWYQQKPGKAPKLLIYWA-------STRHTGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYS-----SYRTFGQGTKVEIK
tildrakizumab QVQLVQSGA-EVKKPGASVKVSCKASGYIF----ITYWMTWVRQAPGQGLEWMGQIFPA--SGSADYNEKFE-GRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGG---------------------GFAYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRTSENI------YSYLAWYQQKPGKAPKLLIYNA-------KTLAEGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQHHYG----IPFTFGQGTKVEIK
tocilizumab QVQLQESGP-GLVRPSQTLSLTCTVSGYSIT---SDHAWSWVRQPPGRGLEWIGYISYS---GITTYNPSLK-SRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLAR------------------TTAMDYWGQGSLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQDI------SSYLNWYQQKPGKAPKLLIYYT-------SRLHSGVP-SRFSGSG--SGTDFTFTISSLQPEDIATYYCQQGNT----LPYTFGQGTKVEIK
tovetumab QVQLVESGG-GLVKPGGSLRLSCAASGFTF----SDYYMNWIRQAPGKGLEWVSYISSS--GSIIYYADSVK-GRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIA-----------------ARGMDVWGQGTTVTVSSDIQMTQSPSSLSASVGDRVSITCRPSQSF------SRYINWYQQKPGKAPKLLIHAA-------SSLVGGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQTYS---NPPITFGQGTRLEMK
tralokinumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----TNYGLSWVRQAPGQGLEWMGWISAN--NGDTNYGQEFQ-GRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSW---------------ARWFFDLWGRGTLVTVSSSYVLTQPPS-VSVAPGKTARITCGGNIIG------SKLVHWYQQKPGQAPVLVIYDD-------GDRPSGIP-ERFSGSN--SGNTATLTISRVEAGDEADYYCQVWDTG--SDPVVFGGGTKLTVL
trastuzumab EVQLVESGG-GLVQPGGSLRLSCAASGFNI----KDTYIHWVRQAPGKGLEWVARIYPT--NGYTRYADSVK-GRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDG-----------------FYAMDYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQDV------NTAVAWYQQKPGKAPKLLIYSA-------SFLYSGVP-SRFSGSR--SGTDFTLTISSLQPEDFATYYCQQHYT----TPPTFGQGTKVEIK
tremelimumab QVQLVESGG-GVVQPGRSLRLSCAASGFTF----SSYGMHWVRQAPGKGLEWVAVIWYD--GSNKYYADSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATL------------YYYYYGMDVWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASQSI------NSYLDWYQQKPGKAPKLLIYAA-------SSLQSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYYS----TPFTFGPGTKVEIK
urelumab QVQLQQWGA-GLLKPSETLSLTCAVYGGSF----SGYYWSWIRQSPEKGLEWIGEINHG---GYVTYNPSLE-SRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGN---------------YDWYFDLWGRGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASQSV------SSYLAWYQQKPGQAPRLLIYDA-------SNRATGIP-ARFSGSG--SGTDFTLTISSLEPEDFAVYYCQQRSNW--PPALTFGGGTKVEIK
ustekinumab EVQLVQSGA-EVKKPGESLKISCKGSGYSF----TTYWLGWVRQMPGKGLDWIGIMSPV--DSDIRYSPSFQ-GQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPG------------------QGYFDFWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASQGI------SSWLAWYQQKPEKAPKSLIYAA-------SSLQSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQYNI----YPYTFGQGTKLEIK
vedolizumab QVQLVQSGA-EVKKPGASVKVSCKGSGYTF----TSYWMHWVRQAPGQRLEWIGEIDPS--ESNTNYNQKFK-GRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDG----------------WDYAIDYWGQGTLVTVSSDVVMTQSPLSLPVTPGEPASISCRSSQSLAKS-YGNTYLSWYLQKPGQSPQLLIYGI-------SNRFSGVP-DRFSGSG--SGTDFTLKISRVEAEDVGVYYCLQGTH----QPYTFGQGTKVEIK
veltuzumab QVQLQQSGA-EVKKPGSSVKVSCKASGYTF----TSYNMHWVKQAPGQGLEWIGAIYPG--MGDTSYNQKFK-GKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYG----------------GDWYFDVWGQGTTVTVSSDIQLTQSPSSLSASVGDRVTMTCRASSSV-------SYIHWFQQKPGKAPKPWIYAT-------SNLASGVP-VRFSGSG--SGTDYTFTISSLQPEDIATYYCQQWTS----NPPTFGGGTKLEIK
visilizumab QVQLVQSGA-EVKKPGASVKVSCKASGYTF----ISYTMHWVRQAPGQGLEWMGYINPR--SGYTHYNQKLK-DKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYD-----------------YDGFAYWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCSASSSV-------SYMNWYQQKPGKAPKRLIYDT-------SKLASGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQWSS----NPPTFGGGTKVEIK
zalutumumab QVQLVESGG-GVVQPGRSLRLSCAASGFTF----STYGMHWVRQAPGKGLEWVAVIWDD--GSYKYYGDSVK-GRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVR------------GVMKDYFDYWGQGTLVTVSSAIQLTQSPSSLSASVGDRVTITCRASQDI------SSALVWYQQKPGKAPKLLIYDA-------SSLESGVP-SRFSGSE--SGTDFTLTISSLQPEDFATYYCQQFNS----YPLTFGGGTKVEIK
zanolimumab QVQLQQWGA-GLLKPSETLSLTCAVYGGSF----SGYYWSWIRQPPGKGLEWIGEINHS---GSTNYNPSLK-SRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVIN---------------------WFDPWGQGTLVTVSSDIQMTQSPSSVSASVGDRVTITCRASQDI------SSWLAWYQHKPGKAPKLLIYAA-------SSLQSGVP-SRFSGSG--SGTDFTLTISSLQPEDFATYYCQQANS----FPYTFGQGTKLEIK
